within Pharmacolibrary.Drugs.ATC.M;

model M02AA27
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 3.1666666666666667e-06,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.027000000000000003,
    Tlag           = 720
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA27</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dexketoprofen is the (S)-enantiomer of ketoprofen, belonging to the non-steroidal anti-inflammatory drug (NSAID) class. It is used for the short-term treatment of mild to moderate acute pain, including musculoskeletal pain and dysmenorrhea. Dexketoprofen is approved for use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy male and female volunteers after administration of a single oral dose.</p><h4>References</h4><ol><li><p>Barbanoj, MJ, et al., &amp; Gich, I (2001). Clinical pharmacokinetics of dexketoprofen. <i>Clinical pharmacokinetics</i> 40(4) 245–262. DOI:<a href=\"https://doi.org/10.2165/00003088-200140040-00002\">10.2165/00003088-200140040-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11368291/\">https://pubmed.ncbi.nlm.nih.gov/11368291</a></p></li><li><p>Barbanoj, MJ, et al., &amp; Mauleón, D (1998). Pharmacokinetics of Dexketoprofen Trometamol in Healthy Volunteers After Single and Repeated Oral Doses. <i>Journal of clinical pharmacology</i> 38(S1) 33S–40S. DOI:<a href=\"https://doi.org/10.1002/jcph.1998.38.s1.33\">10.1002/jcph.1998.38.s1.33</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29023869/\">https://pubmed.ncbi.nlm.nih.gov/29023869</a></p></li><li><p>Barbanoj, MJ, et al., &amp; Mauleón, D (1998). Pharmacokinetics of dexketoprofen trometamol in healthy volunteers after single and repeated oral doses. <i>Journal of clinical pharmacology</i> 38(S1) 33S–40S. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9882080/\">https://pubmed.ncbi.nlm.nih.gov/9882080</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA27;
